Last reviewed · How we verify
Nivea, Topical Cream
Nivea cream provides emollient and moisturizing effects by forming an occlusive barrier on the skin surface to reduce transepidermal water loss.
Nivea cream provides emollient and moisturizing effects by forming an occlusive barrier on the skin surface to reduce transepidermal water loss. Used for General skin moisturization and care, Mild xerosis and dry skin conditions.
At a glance
| Generic name | Nivea, Topical Cream |
|---|---|
| Sponsor | University of Toronto |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | FDA-approved |
Mechanism of action
Nivea is a traditional moisturizing cream containing mineral oil, petrolatum, and other emollients that soften and hydrate the stratum corneum. The occlusive ingredients trap moisture in the skin and protect against environmental irritants, making it suitable for general skin care and mild dermatological conditions.
Approved indications
- General skin moisturization and care
- Mild xerosis and dry skin conditions
Common side effects
- Local skin irritation or contact dermatitis
- Allergic reaction to fragrance or preservatives
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nivea, Topical Cream CI brief — competitive landscape report
- Nivea, Topical Cream updates RSS · CI watch RSS
- University of Toronto portfolio CI